Actively Recruiting

Age: 15Years - 35Years
FEMALE
ID05734287

Frequency of Polycystic Ovary Syndrome Among Young Females With Hyperandrogenism in a Mixed Cohort Study

Led by Woman's Health University Hospital, Egypt · Updated on 2024-07-23

260

Participants Needed

1

Research Sites

2 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying the frequency of polycystic ovary syndrome (PCOS) in young females who show signs of clinical hyperandrogenism such as acne, excess hair growth, and hair loss. The diagnosis will follow the recent international guidelines published in 2018 for assessing and managing PCOS. This observational study aims to better understand how common PCOS is among this group of young women. The study involves clinical, biophysical, and biochemical assessments of young females with signs of hyperandrogenism. These assessments include evaluating symptoms like acne, hirsutism, and alopecia, as well as measuring hormone levels such as free testosterone and androgen indices. Ultrasound imaging will be used cautiously depending on gynecological age to assess ovarian morphology. The study does not involve any treatment but focuses on diagnostic testing. Participants will undergo comprehensive history taking and physical exams to identify clinical signs of hyperandrogenism. Hormonal blood tests and ultrasounds will be conducted to support diagnosis. Researchers will measure the frequency of PCOS over a 7-month period. The involvement includes monitoring menstrual irregularities, biochemical markers, and ovarian structure. Participants will be closely observed without any intervention, and the study is expected to provide important data on PCOS occurrence in this population.

CONDITIONS

Brief Title

The Frequency of Polycystic Ovary Syndrome Among Young Reproductive Females Presenting With Hyperandrogenism: a Mixed Cohort Study

Who Can Participate

Age: 15Years - 35Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinical hyperandrogenism such as acne, hirsutism, or hair loss
Not Eligible

You will not qualify if you...

  • Age less than 15 years
  • Age greater than 35 years

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Up to 7 months

Participants undergo clinical, biophysical, and biochemical assessments to evaluate hyperandrogenism and search for polycystic ovary syndrome (PCOS).

1 to 2 visits depending on assessments

Trial Site Locations

Total: 1 location

1

Atif Dervis

Doha, Qatar

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Letrozole Alone vs. Letrozole Plus Levothyroxine for Ovulati...

PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

Actively Recruiting

1 location

Impact of Adding Quercetin or Alpha Lipoic Acid on Clinical ...

PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

Actively Recruiting

1 location

IVF/ICSI Outcomes in Women With Polycystic Ovary Syndrome Co...

PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here